Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABSCF OTCMKTS:BIOYF TSE:CSI NASDAQ:IMCC OTCMKTS:TGIFF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABSCFAB Science$1.26$1.44$0.80▼$1.60N/AN/A200 shsN/ABIOYFBioSyent$8.69-1.3%$8.43$6.49▼$8.90N/AN/A2,613 shs290 shsCSIColossus MineralsC$0.00C$0.01▼C$3.40N/AN/A158,798 shsN/AIMCCIM Cannabis$3.55+5.3%$2.49$1.29▼$7.12$13.61M2.1996,335 shs42,276 shsTGIFF1933 Industries$0.01+47.2%$0.00$0.00▼$0.01N/AN/A135,176 shs38,407 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABSCFAB Science0.00%0.00%0.00%-19.75%-53.33%BIOYFBioSyent-1.25%+0.75%+1.88%+17.75%+16.02%IMCCIM Cannabis+5.34%+34.47%+33.96%+165.92%+76.09%TGIFF1933 Industries+47.22%+15.22%+39.47%+26.19%-46.73%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABSCFAB ScienceN/AN/AN/AN/AN/AN/AN/AN/ABIOYFBioSyentN/AN/AN/AN/AN/AN/AN/AN/ACSIColossus MineralsN/AN/AN/AN/AN/AN/AN/AN/AIMCCIM Cannabis0.3404 of 5 stars0.05.00.00.00.60.00.0TGIFF1933 IndustriesN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABSCFAB Science 0.00N/AN/AN/ABIOYFBioSyent 0.00N/AN/AN/ACSIColossus Minerals 0.00N/AN/AN/AIMCCIM Cannabis 0.00N/AN/AN/ATGIFF1933 Industries 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABSCFAB ScienceN/AN/AN/AN/AN/AN/ABIOYFBioSyentN/AN/AN/AN/AN/AN/ACSIColossus MineralsN/AN/AN/AN/AN/AN/AIMCCIM Cannabis$39.44M0.36N/AN/A$1.03 per share3.45TGIFF1933 IndustriesN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABSCFAB ScienceN/AN/A0.00∞N/AN/AN/AN/AN/ABIOYFBioSyentN/A$0.2042.70∞N/AN/AN/AN/A8/25/2025 (Estimated)CSIColossus MineralsN/AN/A0.00N/AN/AN/AN/AN/AN/AIMCCIM Cannabis-$7.72M-$0.64N/AN/AN/A-9.10%-122.96%-11.69%8/13/2025 (Estimated)TGIFF1933 IndustriesN/AN/A0.00∞N/AN/AN/AN/AN/ALatest BIOYF, CSI, IMCC, TGIFF, and ABSCF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025IMCCIM Cannabis-$0.2540$0.06+$0.3140$0.06$11.45 million$8.69 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABSCFAB ScienceN/AN/AN/AN/AN/ABIOYFBioSyentN/AN/AN/AN/AN/ACSIColossus MineralsN/AN/AN/AN/AN/AIMCCIM CannabisN/AN/AN/AN/AN/ATGIFF1933 IndustriesN/AN/AN/AN/AN/ALatest BIOYF, CSI, IMCC, TGIFF, and ABSCF DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/24/2025BIOYFBioSyent$0.03571.64%5/30/20256/2/20256/13/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABSCFAB ScienceN/AN/AN/ABIOYFBioSyentN/AN/AN/ACSIColossus MineralsN/AN/AN/AIMCCIM Cannabis0.100.720.59TGIFF1933 IndustriesN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABSCFAB ScienceN/ABIOYFBioSyent0.08%CSIColossus MineralsN/AIMCCIM Cannabis7.68%TGIFF1933 IndustriesN/AInsider OwnershipCompanyInsider OwnershipABSCFAB ScienceN/ABIOYFBioSyentN/ACSIColossus MineralsN/AIMCCIM Cannabis5.91%TGIFF1933 IndustriesN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABSCFAB Science51N/AN/ANot OptionableBIOYFBioSyentN/AN/AN/ANot OptionableCSIColossus MineralsN/AN/AN/ANot OptionableIMCCIM Cannabis3404.04 million3.81 millionNot OptionableTGIFF1933 Industries87N/AN/ANot OptionableBIOYF, CSI, IMCC, TGIFF, and ABSCF HeadlinesRecent News About These Companies1933 Industries Reports Profit in Q3 2025 Amidst Industry ChallengesJune 16, 2025 | tipranks.com1933 Industries Reports Profit in Third Quarter 2025 Financial ResultsJune 16, 2025 | accessnewswire.comA1933 Industries Completes Full Acquisition of AMA SubsidiaryJune 2, 2025 | tipranks.com1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production SubsidiaryJune 2, 2025 | accessnewswire.comA1933 Industries Completes Acquisition of Remaining Interest in SubsidiaryMay 22, 2025 | tipranks.com1933 Industries To Complete Purchase of 9% Interest of Cultivation and Production SubsidiaryMay 22, 2025 | accessnewswire.comA1933 Industries Stock Short Interest Report | OTC:TGIFF | BenzingaApril 21, 2025 | benzinga.com1933 sees uptick in revenue in NevadaApril 2, 2025 | greenmarketreport.comG1933 Industries Reports Second Quarter 2025 Financial ResultsMarch 31, 2025 | accessnewswire.comACSE Bulletin: Reinstatement - 1933 Industries Inc. (TGIF)March 6, 2025 | newsfilecorp.comN1933 Industries Inc.: 1933 Industries Announces First Quarter 2025 Financial ReportFebruary 28, 2025 | finanznachrichten.de1933 Industries Announces First Quarter 2025 Financial ReportFebruary 27, 2025 | accessnewswire.comA1933 Industries Inc.: 1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 27, 2025 | finanznachrichten.de1933 Industries losses contract year-over-year, but company still in the redFebruary 26, 2025 | greenmarketreport.comG1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 MillionFebruary 25, 2025 | accessnewswire.comA1933 Industries Appoints New CFO and VP FinanceJanuary 31, 2025 | accessnewswire.comA1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportJanuary 24, 2025 | accessnewswire.comA1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | finanznachrichten.de1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management ChangesJanuary 11, 2025 | markets.businessinsider.com1933 Industries Inc.: 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly ReportDecember 27, 2024 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBIOYF, CSI, IMCC, TGIFF, and ABSCF Company DescriptionsAB Science OTCMKTS:ABSCF$1.26 0.00 (0.00%) As of 07/7/2025AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.BioSyent OTCMKTS:BIOYF$8.69 -0.11 (-1.25%) As of 07/9/2025 11:35 AM EasternBioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.Colossus Minerals TSE:CSIColossus Minerals Inc. (Colossus) is a development-stage mining company. Colossus is focused on its Serra Pelada project into production. The Serra Pelada Project is located in the mineral prolific Carajas region in Para, Brazil, is host to high grade gold and platinum group metals deposit. The Company's three mineral properties in Brazil: the Serra Pelada Project, the Rio Cristalino Property and the Cutia Property. The Serra Pelada Project is the only material property of the Company. The Company's subsidiaries include Colossus Mineracao Ltda., Mineracao Fazenda Monte Belo Ltda., Serra Pelada - Companhia de Desenvolvimento Mineral, and Grifo Geologia e Participacoes Ltda. In January 2012, the Company acquired Cutia Property from Cooperativa Mista do Garimpeiro de Cutia.IM Cannabis NASDAQ:IMCC$3.55 +0.18 (+5.34%) Closing price 07/9/2025 03:54 PM EasternExtended Trading$3.46 -0.09 (-2.54%) As of 07/9/2025 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.1933 Industries OTCMKTS:TGIFF$0.0053 +0.00 (+47.22%) As of 07/9/2025 03:00 PM Eastern1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Why Marvell Could Be the Smartest AI Bet Under $80 Autodesk Stock Ready to Rip? Q3 May Be the Turning Point Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
